Mexico, PAHO Advance HEARTS Cardiovascular Data Monitoring

Mexico strengthened data monitoring, evaluation, and interoperability under PAHO's HEARTS cardiovascular initiative through an August 2026 technical workshop involving IMSS, ISSSTE, PEMEX, and IMSS-Bienestar. The effort addresses fragmented health information systems and aims to establish a consensus-based national denominator of enabled facilities, supporting data-driven cardiovascular care management. Stakeholders across Mexico's public health institutions, health IT providers, and pharmaceutical companies are affected as interoperability becomes a prerequisite for scaling primary care interventions against hypertension and cardiovascular disease, the country's leading cause of death. 

Mexico's Ministry of Health and the Pan American Health Organization (PAHO) concluded a three-day technical workshop in Mexico City aimed at strengthening monitoring, evaluation, and interoperability under the HEARTS cardiovascular initiative. The sessions brought together IMSS, ISSSTE, PEMEX, IMSS-Bienestar, and federal health authorities to align data systems and evaluation methods nationwide. 

Cardiovascular disease remains the leading cause of death nationally, and the data infrastructure needed to track and improve care has historically lagged behind clinical need. The workshop, led by HEARTS in the Americas technical specialists, focused on reviewing national progress, consolidating technical processes, and defining operational agreements to support decision-making in cardiovascular care. Participating teams analyzed results from more than 2,000 self-assessed health centers across the country and discussed methodologies to establish, by consensus, the national denominator of facilities formally enabled to implement HEARTS, a step PAHO identifies as essential for national monitoring and progress evaluation. 

HEARTS in the Americas is PAHO's regional technical package for hypertension control and cardiovascular disease prevention in primary care, active in Mexico since 2020 under the domestic name Corazones Mexico. The August workshop extends a series of national engagements PAHO has convened with Mexican authorities over the past 18 months to institutionalize the model across the country's fragmented health subsystems.  

The push for stronger monitoring and interoperability also aligns with a broader shift underway in Mexico's health sector, where institutions including IMSS are prioritizing data infrastructure as a strategic asset. IMSS has accumulated more than 53.7 million medical records and is now pursuing interoperability with IMSS-Bienestar and AI-driven analytics to move from basic record-keeping toward system-wide decision-making support . That same interoperability logic underpins the HEARTS workshop's emphasis on connecting cardiovascular risk data across institutional lines rather than treating it as siloed reporting.  

The technical mission moved to CENAPRECE facilities for a session dedicated specifically to interoperability among Mexico's health information systems, gathering representatives from the country's various service-provider subsystems and the Ministry of Health to address barriers to data exchange between HEARTS and national platforms. The agenda also covered technical progress on integrating the HEARTS Cardiovascular Risk Calculator API with existing digital tools, a component PAHO frames as central to scaling data-driven cardiovascular management. Institutions participating in the workshop included CENAPRECE, ISSSTE, PEMEX, IMSS, IMSS-Bienestar, the National Institute of Public Health (INSP), the General Directorate of Health Information (DGIS), the General Directorate of Quality and Health Education (DGCES), the Directorate for Evaluation and Management of the Health Services Model (DGMoSS), and the General Directorate of Epidemiology (DGE).

As a result of the sessions, participating institutions reached agreements to improve data quality and management, advance interoperability among information systems, and continue expanding and institutionalizing HEARTS across Mexico's health subsystems. The outcomes reinforce a point Mexico's pharmaceutical industry has also flagged as a priority: cardiovascular disease, alongside diabetes, obesity, and hypertension, represents the country's highest disease and cost burden, according to the National Chamber of the Pharmaceutical Industry (CANIFARMA), which has called for primary care efforts to remain concentrated on these conditions.  

For stakeholders across Mexico's health sector, from public payers to medical device and diagnostics companies, the workshop signals that data governance and cross-institutional interoperability are becoming prerequisites for scaling cardiovascular interventions nationally, rather than secondary technical concerns. PAHO indicates that strengthening these monitoring and evaluation competencies is expected to support more effective HEARTS implementation and contribute to Mexico's broader objective of improving cardiovascular disease prevention and control from the primary care level.